At the phenotypic level, Iltzsche et al. discovered that MKLP1 was required for the development of lung tumours in genetically engineered mouse models of NSCLC driven by the loss of p53 and KRAS activation [112]. Here, KIF23 is linked to non-small cell lung carcinoma.